Finding biological markers for schizophrenia and bipolar spectrum disorders
The Psychiatric Biomarker Network (formerly the Schizophrenia Spectrum Biomarkers Consortium) was established in November 2018 as a consortium of academic investigators and colleagues from industry with the goal of discovering robust, replicable, and measurable biological markers to support clinical trials for schizophrenia and bipolar spectrum disorders.
Information for Individuals and Families
The Psychiatric Biomarkers Network recognizes how crucial it is for individuals with mental health conditions and their family members to get informed, stay engaged, and feel supported throughout the experience of diagnosis and treatment or while engaged in a research study.
